{"entity":{"type":"insider","cik":"0001658550","url":"/insider/0001658550","json_url":"/insider/0001658550.json","name":"Skwierczynski Raymond","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2016-06-22","last":"2016-08-31","span_basis":"filed_date"},"name_variants":[{"name":"Skwierczynski Raymond","source":"filing","n_filings":8,"first_seen":"2016-06-22","last_seen":"2016-08-31"}],"transactions":[{"id":2544561,"accession":"0000911916-16-000650","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-16-000650","line_url":"/filing/0000911916-16-000650#line-1","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001658550","owner_name":"Skwierczynski Raymond","owner_display_name":"Skwierczynski Raymond","owner_url":"/insider/0001658550","role":"Officer (Head,Pharmaceutical Operations)","role_mark":"O","role_mark_label":"Officer (Head,Pharmaceutical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head,Pharmaceutical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":10.86,"price_display":"10.86","price_state":"stated","total_value":1629.0,"total_display":"1,629.00","total_whole":"1,629","shares_owned_after":47.0,"shares_owned_after_display":"47","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-31","filed_date":"2016-08-31","scope":"insider"},{"id":2647085,"accession":"0000911916-16-000646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-16-000646","line_url":"/filing/0000911916-16-000646#line-1","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001658550","owner_name":"Skwierczynski Raymond","owner_display_name":"Skwierczynski Raymond","owner_url":"/insider/0001658550","role":"Officer (Head,Pharmaceutical Operations)","role_mark":"O","role_mark_label":"Officer (Head,Pharmaceutical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head,Pharmaceutical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508.0,"shares_display":"508","price_per_share":8.41,"price_display":"8.41","price_state":"stated","total_value":4272.28,"total_display":"4,272.28","total_whole":"4,272","shares_owned_after":197.0,"shares_owned_after_display":"197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-19","filed_date":"2016-08-19","scope":"insider"},{"id":2417545,"accession":"0000911916-16-000640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-16-000640","line_url":"/filing/0000911916-16-000640#line-1","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001658550","owner_name":"Skwierczynski Raymond","owner_display_name":"Skwierczynski Raymond","owner_url":"/insider/0001658550","role":"Officer (Head,Pharmaceutical Operations)","role_mark":"O","role_mark_label":"Officer (Head,Pharmaceutical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head,Pharmaceutical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508.0,"shares_display":"508","price_per_share":8.3,"price_display":"8.30","price_state":"stated","total_value":4216.4,"total_display":"4,216.40","total_whole":"4,216","shares_owned_after":705.0,"shares_owned_after_display":"705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-10","filed_date":"2016-08-10","scope":"insider"},{"id":2819771,"accession":"0000911916-16-000632","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-16-000632","line_url":"/filing/0000911916-16-000632#line-1","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001658550","owner_name":"Skwierczynski Raymond","owner_display_name":"Skwierczynski Raymond","owner_url":"/insider/0001658550","role":"Officer (Head,Pharmaceutical Operations)","role_mark":"O","role_mark_label":"Officer (Head,Pharmaceutical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head,Pharmaceutical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508.0,"shares_display":"508","price_per_share":9.085,"price_display":"9.08","price_state":"stated","total_value":4615.18,"total_display":"4,615.18","total_whole":"4,615","shares_owned_after":1213.0,"shares_owned_after_display":"1,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-29","filed_date":"2016-07-29","scope":"insider"},{"id":3070080,"accession":"0000911916-16-000630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-16-000630","line_url":"/filing/0000911916-16-000630#line-1","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001658550","owner_name":"Skwierczynski Raymond","owner_display_name":"Skwierczynski Raymond","owner_url":"/insider/0001658550","role":"Officer (Head,Pharmaceutical Operations)","role_mark":"O","role_mark_label":"Officer (Head,Pharmaceutical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head,Pharmaceutical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508.0,"shares_display":"508","price_per_share":8.97,"price_display":"8.97","price_state":"stated","total_value":4556.76,"total_display":"4,556.76","total_whole":"4,557","shares_owned_after":1721.0,"shares_owned_after_display":"1,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-20","filed_date":"2016-07-20","scope":"insider"},{"id":2647079,"accession":"0000911916-16-000626","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-16-000626","line_url":"/filing/0000911916-16-000626#line-1","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001658550","owner_name":"Skwierczynski Raymond","owner_display_name":"Skwierczynski Raymond","owner_url":"/insider/0001658550","role":"Officer (Head,Pharmaceutical Operations)","role_mark":"O","role_mark_label":"Officer (Head,Pharmaceutical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head,Pharmaceutical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508.0,"shares_display":"508","price_per_share":9.1,"price_display":"9.10","price_state":"stated","total_value":4622.8,"total_display":"4,622.80","total_whole":"4,623","shares_owned_after":2229.0,"shares_owned_after_display":"2,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-11","filed_date":"2016-07-12","scope":"insider"},{"id":2056960,"accession":"0000911916-16-000600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-16-000600","line_url":"/filing/0000911916-16-000600#line-1","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001658550","owner_name":"Skwierczynski Raymond","owner_display_name":"Skwierczynski Raymond","owner_url":"/insider/0001658550","role":"Officer (Head,Pharmaceutical Operations)","role_mark":"O","role_mark_label":"Officer (Head,Pharmaceutical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head,Pharmaceutical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":516.0,"shares_display":"516","price_per_share":7.011,"price_display":"7.01","price_state":"stated","total_value":3617.676,"total_display":"3,617.68","total_whole":"3,618","shares_owned_after":2737.0,"shares_owned_after_display":"2,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-30","filed_date":"2016-06-30","scope":"insider"},{"id":2311409,"accession":"0000911916-16-000596","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000596","line_url":"/filing/0000911916-16-000596#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001658550","owner_name":"Skwierczynski Raymond","owner_display_name":"Skwierczynski Raymond","owner_url":"/insider/0001658550","role":"Officer (Head,Pharmaceutical Operations)","role_mark":"O","role_mark_label":"Officer (Head,Pharmaceutical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head,Pharmaceutical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":3500.0,"total_display":"3,500.00","total_whole":"3,500","shares_owned_after":3253.0,"shares_owned_after_display":"3,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-20","filed_date":"2016-06-22","scope":"insider"},{"id":2311405,"accession":"0000911916-16-000596","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-16-000596","line_url":"/filing/0000911916-16-000596#line-1","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001658550","owner_name":"Skwierczynski Raymond","owner_display_name":"Skwierczynski Raymond","owner_url":"/insider/0001658550","role":"Officer (Head,Pharmaceutical Operations)","role_mark":"O","role_mark_label":"Officer (Head,Pharmaceutical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head,Pharmaceutical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508.0,"shares_display":"508","price_per_share":6.5984,"price_display":"6.60","price_state":"stated","total_value":3351.9872,"total_display":"3,351.99","total_whole":"3,352","shares_owned_after":3753.0,"shares_owned_after_display":"3,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-10","filed_date":"2016-06-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348649","name":"CoLucid Pharmaceuticals, Inc.","url":"/issuer/0001348649","role":"Officer (Head,Pharmaceutical Operations)","n_filings":8,"first_seen":"2016-06-22","last_seen":"2016-08-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001658550","retrieved_at":"2026-08-27T14:11:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}